• Users Online: 777
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe News Contacts Login 
REVIEW ARTICLE
Year : 2020  |  Volume : 4  |  Issue : 3  |  Page : 67-74

Cardiovascular complications of COVID-19


1 Department of Heart and Vessels, Division of Cardiology, Centro Hospitalar Universitário Lisboa Norte, Cardiovascular Centre of Universidade de Lisboa (CCUL), Lisbon School of Medicine, Universidade de Lisboa, Lisbon, Portugal
2 Department of Heart and Vessels, Division of Cardiology, Centro Hospitalar Universitário Lisboa Norte, Cardiovascular Centre of Universidade de Lisboa (CCUL), Lisbon School of Medicine, Universidade de Lisboa; Department of Intensive Care, Centro Hospitalar Universitário Lisboa Norte, Santa Maria University Hospital, Lisbon, Portugal

Correspondence Address:
Prof. Fausto J Pinto
Department of Heart and Vessels, Division of Cardiology, Santa Maria University Hospital, Av. Prof. Egas Moniz, 1649 028, Lisboa
Portugal
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/hm.hm_28_20

Rights and Permissions

Coronavirus disease 19 (COVID-19) has rapidly expanded to a global pandemic, resulting in significant morbidity and mortality. Even though predictors of infection remain unclear, age and preexisting cardiovascular conditions have been clearly identified as predictors of adverse outcomes and higher fatality rates. Since the virus infects host cells through angiotensin-converting enzyme 2 receptors, a key player in the renin-angiotensin-aldosterone system, the interaction between the cardiovascular system and the progression of COVID-19 is nowadays a focus of huge interest. In this review, the authors analyze the available and very recent evidence on the risk factors and mechanisms of the most relevant cardiovascular complications associated with COVID-19, including acute cardiac injury, myocarditis, stress-cardiomyopathy, ischemic myocardial injury, cytokine release syndrome, thrombotic disease, cardiac arrhythmias, heart failure, and cardiogenic shock. Finally, we discuss the cardiovascular impact of the therapies under investigation for COVID-19 treatment.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed18532    
    Printed89    
    Emailed0    
    PDF Downloaded1691    
    Comments [Add]    
    Cited by others 3    

Recommend this journal